These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29300899)

  • 1. Tissue Distribution of Suvorexant in Three Forensic Autopsy Cases.
    Waters B; Hara K; Ikematsu N; Takayama M; Matsusue A; Kashiwagi M; Kubo SI
    J Anal Toxicol; 2018 May; 42(4):276-283. PubMed ID: 29300899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of suvorexant in urine using gas chromatography/mass spectrometry.
    Carson M; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():289-294. PubMed ID: 27825624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Suvorexant in Blood Using LC-MS-MS: Important Considerations for Matrix Effects and Quantitative Interferences in Targeted Assays.
    Skillman B; Kerrigan S
    J Anal Toxicol; 2020 Apr; 44(3):245-255. PubMed ID: 31788700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of suvorexant in blood using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry.
    Skillman B; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():87-95. PubMed ID: 29859493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP450-Mediated metabolism of suvorexant and investigation of metabolites in forensic case specimens.
    Skillman B; Kerrigan S
    Forensic Sci Int; 2020 Jul; 312():110307. PubMed ID: 32473525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Suvorexant in Urine Using Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry (LC-Q/TOF-MS).
    Sullinger S; Bryand K; Kerrigan S
    J Anal Toxicol; 2017 Apr; 41(3):224-229. PubMed ID: 28035034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of suvorexant in human plasma using 96-well liquid-liquid extraction and HPLC with tandem mass spectrometric detection.
    Breidinger SA; Simpson RC; Mangin E; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():254-9. PubMed ID: 26343269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple and Highly Sensitive UPLC-ESI-MS/MS Assay for Rapid Determination of Suvorexant in Plasma.
    Iqbal M; Ezzeldin E; Khalil NY; Al-Rashood ST; Al-Rashood KA
    J Anal Toxicol; 2017 Mar; 41(2):114-120. PubMed ID: 28376227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suvorexant: a novel therapy for the treatment of insomnia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2014 Oct; 52(10):23-6. PubMed ID: 25291725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects.
    Uemura N; McCrea J; Sun H; Donikyan M; Zammit G; Liu R; Louridas B; Marsilio S; Lines C; Troyer MD; Wagner J
    J Clin Pharmacol; 2015 Oct; 55(10):1093-100. PubMed ID: 25903940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suvorexant: efficacy and safety profile of a dual orexin receptor antagonist in treating insomnia.
    Owen RT
    Drugs Today (Barc); 2016 Jan; 52(1):29-40. PubMed ID: 26937493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual orexin receptor blocker suvorexant attenuates hypercapnic ventilatory augmentation in mice.
    Fukushi I; Yokota S; Takeda K; Terada J; Umeda A; Yoshizawa M; Kono Y; Hasebe Y; Onimaru H; Pokorski M; Okada Y
    Brain Res; 2022 Nov; 1795():148061. PubMed ID: 36037880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterisation of the metabolism and disposition of suvorexant in humans.
    Cui D; Cabalu T; Yee KL; Small J; Li X; Liu B; Maciolek C; Smith S; Liu W; McCrea JB; Prueksaritanont T
    Xenobiotica; 2016 Oct; 46(10):882-95. PubMed ID: 26864332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a preparation method to produce a single sample that can be applied to both LC-MS/MS and GC-MS for the screening of postmortem specimens.
    Hara K; Waters B; Ikematsu N; Tokuyasu T; Fujii H; Takayama M; Matsusue A; Kashiwagi M; Kubo S
    Leg Med (Tokyo); 2016 Jul; 21():85-92. PubMed ID: 27497339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical assessment of the abuse potential of the orexin receptor antagonist, suvorexant.
    Born S; Gauvin DV; Mukherjee S; Briscoe R
    Regul Toxicol Pharmacol; 2017 Jun; 86():181-192. PubMed ID: 28279667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of drug screening in forensic autopsy: retrospective investigation of routine toxicological findings.
    Tominaga M; Michiue T; Inamori-Kawamoto O; Hishmat AM; Oritani S; Takama M; Ishikawa T; Maeda H
    Leg Med (Tokyo); 2015 May; 17(3):172-6. PubMed ID: 25637163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist.
    Winrow CJ; Gotter AL; Cox CD; Doran SM; Tannenbaum PL; Breslin MJ; Garson SL; Fox SV; Harrell CM; Stevens J; Reiss DR; Cui D; Coleman PJ; Renger JJ
    J Neurogenet; 2011 Mar; 25(1-2):52-61. PubMed ID: 21473737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease.
    Sun H; Palcza J; Rosenberg R; Kryger M; Siringhaus T; Rowe J; Lines C; Wagner JA; Troyer MD
    Respir Med; 2015 Mar; 109(3):416-26. PubMed ID: 25661282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.